Comparative efficacy of adjuvant trastuzumab-containing chemotherapies for patients with early HER2-positive primary breast cancer: a network meta-analysis.
Lianchun XiaoT FujiiN T UenoD TripathyN FuH ZhouJ NingL XiaoPublished in: Breast cancer research and treatment (2018)
Concurrent H with ACT or TC showed most clinical benefit for early-stage HER2+ BC; TC+H had lowest cardiotoxicity.